KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Cash (2016 - 2026)

Biomarin Pharmaceutical has reported Change in Cash over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash rose 1561.7% year-over-year to $1.8 billion, compared with a TTM value of $2.0 billion through Mar 2026, up 570.51%, and an annual FY2025 reading of $368.8 million, up 96.49% over the prior year.
  • Change in Cash came in at $1.8 billion for Q1 2026, up from $61.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $1.8 billion in Q1 2026 to a low of -$296.7 million in Q3 2024.
  • Median Change in Cash over the past 5 years was $61.6 million (2025), compared with a mean of $146.2 million.
  • The sharpest move saw Change in Cash crashed 895.29% in 2023, then surged 1561.7% in 2026.
  • Over 5 years, Change in Cash stood at -$37.0 million in 2022, then increased by 18.11% to -$30.3 million in 2023, then skyrocketed by 982.87% to $267.4 million in 2024, then plummeted by 76.97% to $61.6 million in 2025, then skyrocketed by 2759.72% to $1.8 billion in 2026.
  • Per Business Quant, the three most recent readings for BMRN's Change in Cash are $1.8 billion (Q1 2026), $61.6 million (Q4 2025), and $36.3 million (Q3 2025).